RECOMBINANT LEUKOCYTE A-INTERFERON - AN ACTIVE AGENT IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS

被引：231

作者：

BUNN, PA

FOON, KA

IHDE, DC

LONGO, DL

EDDY, J

WINKLER, CF

VEACH, SR

ZEFFREN, J

SHERWIN, S

OLDHAM, R

机构：

[1] NCI, DIV CANC TREATMENT, PROGRAM BIOL RESPONSE MODIFIERS, BETHESDA, MD 20205 USA

[2] HOFFMANN LA ROCHE INC, NUTLEY, NJ 07110 USA

[3] NCI, DIV CANC TREATMENT, PROGRAM CLIN ONCOL, BETHESDA, MD 20205 USA

来源：

关键词：

D O I：

10.7326/0003-4819-101-4-484

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：484 / 487

页数：4

共 27 条

[21] PRICE NM, 1977, CANCER, V40, P2851, DOI 10.1002/1097-0142(197712)40:6<2851::AID-CNCR2820400615>3.0.CO
[22] 2-X
[23] ROENIGK HH, 1979, CANCER TREAT REP, V63, P669
[24] A MULTIPLE-DOSE PHASE-I TRIAL OF RECOMBINANT LEUKOCYTE-A INTERFERON IN CANCER-PATIENTS
SHERWIN, SA
KNOST, JA
FEIN, S
ABRAMS, PG
FOON, KA
OCHS, JJ
SCHOENBERGER, C
MALUISH, AE
OLDHAM, RK
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (19): : 2461 - 2466
[25] VONDERHEID EC, 1979, CANCER TREAT REP, V63, P681
[26] WALDRON JA, 1977, CANCER, V40, P1604, DOI 10.1002/1097-0142(197710)40:4<1604::AID-CNCR2820400433>3.0.CO
[27] 2-H